⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer

Official Title: Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer

Study ID: NCT00921193

Conditions

Prostate Cancer

Study Description

Brief Summary: The study aims to evaluate the safety and performance of the RTPS in patients with localized prostate cancer.The RTPS is an investigational device and requires permanent implantation of a small radioactive fiducial, called the Blip, in the prostate.

Detailed Description: The high precision of planned radiotherapy treatments requires accurate positioning of the prostate in order to ensure that the tightly conformed dose distribution does not miss the prostate and result in either significant tumor underdosage, an increased dose to the rectum or bladder, or both. Precise delivery has been addressed using a variety of pre-treatment localization systems. The most direct localization of the prostate involves the use of ultrasound, computed tomography (CT), or radiography of permanently implanted fiducial markers. In this study the safety and performance of a novel investigational tracking system will be evaluated. The Radiation Therapy Positioning System (RTPS) is a radioactive tracking system integrated into the radiotherapy set-up workflow. The System is composed of the Clinical Positioning System (CPS) and a radioactive soft tissue implanted fiducial (Blip), which is permanently implanted in the prostate. By tracking the implanted Blip, the CPS can monitor positional changes prior to and during the treatment. The accuracy of the RTPS localization will be compared to the CBCT in at least 5 radiation therapy sessions per patient.

Eligibility

Minimum Age: 45 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

Leuvens Kankerinstituut, Leuven, , Belgium

Dr. Bernard Verbeeten Institute, Tilburg, , Netherlands

Contact Details

Name: Philip MP Poortmans, MD, PhD

Affiliation: Dr. Bernard Verbeeten Instituut

Role: PRINCIPAL_INVESTIGATOR

Name: Willy JM de Kruijf, PhD

Affiliation: Dr. Bernard Verbeeten Instituut

Role: PRINCIPAL_INVESTIGATOR

Name: Karin Haustermans, MD

Affiliation: Leuvens Kankerinstituut

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: